Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    12663709 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Other: Withdrawal of antiandrogen therapy
2 Recruiting Cultured Circulating Tumor Cells in Prostate and Other Cancers
Condition: Prostate Cancer
Intervention:
3 Completed Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: suramin;   Drug: Suramin

Indicates status has not been verified in more than two years